These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37161050)

  • 41. T-cell immunoglobulin and ITIM domain, as a potential immune checkpoint target for immunotherapy of colorectal cancer.
    Fathi M; Pustokhina I; Kuznetsov SV; Khayrullin M; Hojjat-Farsangi M; Karpisheh V; Jalili A; Jadidi-Niaragh F
    IUBMB Life; 2021 May; 73(5):726-738. PubMed ID: 33686787
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CD8 Treg-Mediated Suppression of Naive CD4+ T Cell Differentiation into Follicular Helper T Cells.
    Kasahara TM; Gupta S
    Int Arch Allergy Immunol; 2022; 183(6):682-692. PubMed ID: 34959235
    [TBL] [Abstract][Full Text] [Related]  

  • 43. T-Cell Immunoglobulin and ITIM Domain (TIGIT) Associates with CD8+ T-Cell Exhaustion and Poor Clinical Outcome in AML Patients.
    Kong Y; Zhu L; Schell TD; Zhang J; Claxton DF; Ehmann WC; Rybka WB; George MR; Zeng H; Zheng H
    Clin Cancer Res; 2016 Jun; 22(12):3057-66. PubMed ID: 26763253
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatocellular Carcinoma Cells Up-regulate PVRL1, Stabilizing PVR and Inhibiting the Cytotoxic T-Cell Response via TIGIT to Mediate Tumor Resistance to PD1 Inhibitors in Mice.
    Chiu DK; Yuen VW; Cheu JW; Wei LL; Ting V; Fehlings M; Sumatoh H; Nardin A; Newell EW; Ng IO; Yau TC; Wong CM; Wong CC
    Gastroenterology; 2020 Aug; 159(2):609-623. PubMed ID: 32275969
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tim-3 signaling blockade with α-lactose induces compensatory TIGIT expression in Plasmodium berghei ANKA-infected mice.
    Zhang Y; Jiang N; Zhang T; Chen R; Feng Y; Sang X; Yang N; Chen Q
    Parasit Vectors; 2019 Nov; 12(1):534. PubMed ID: 31711531
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of murine lupus with TIGIT-Ig.
    Liu S; Sun L; Wang C; Cui Y; Ling Y; Li T; Lin F; Fu W; Ding M; Zhang S; Lei C; Hu S
    Clin Immunol; 2019 Jun; 203():72-80. PubMed ID: 31005675
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Cross-Species Reactive TIGIT-Blocking Antibody Fc Dependently Confers Potent Antitumor Effects.
    Yang F; Zhao L; Wei Z; Yang Y; Liu J; Li Y; Tian X; Liu X; Lü X; Sui J
    J Immunol; 2020 Oct; 205(8):2156-2168. PubMed ID: 32887749
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antagonistic and agonistic anti-canine CD28 monoclonal antibodies: tools for allogeneic transplantation.
    Graves SS; Stone DM; Loretz C; Peterson LJ; Lesnikova M; Hwang B; Georges GE; Nash R; Storb R
    Transplantation; 2011 Apr; 91(8):833-40. PubMed ID: 21343872
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stress-elicited glucocorticoid receptor signaling upregulates TIGIT in innate-like invariant T lymphocytes.
    Rudak PT; Gangireddy R; Choi J; Burhan AM; Summers KL; Jackson DN; Inoue W; Haeryfar SMM
    Brain Behav Immun; 2019 Aug; 80():793-804. PubMed ID: 31108170
    [TBL] [Abstract][Full Text] [Related]  

  • 50. TIGIT, the Next Step Towards Successful Combination Immune Checkpoint Therapy in Cancer.
    Ge Z; Peppelenbosch MP; Sprengers D; Kwekkeboom J
    Front Immunol; 2021; 12():699895. PubMed ID: 34367161
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Implication of TIGIT
    Hasan MM; Nair SS; O'Leary JG; Thompson-Snipes L; Nyarige V; Wang J; Park W; Stegall M; Heilman R; Klintmalm GB; Joo H; Oh S
    Nat Commun; 2021 Mar; 12(1):1534. PubMed ID: 33750787
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enhanced antitumor efficacy of a novel oncolytic vaccinia virus encoding a fully monoclonal antibody against T-cell immunoglobulin and ITIM domain (TIGIT).
    Zuo S; Wei M; He B; Chen A; Wang S; Kong L; Zhang Y; Meng G; Xu T; Wu J; Yang F; Zhang H; Wang S; Guo C; Wu J; Dong J; Wei J
    EBioMedicine; 2021 Feb; 64():103240. PubMed ID: 33581644
    [TBL] [Abstract][Full Text] [Related]  

  • 53. TIGIT signalling pathway negatively regulates CD4
    Mao L; Hou H; Wu S; Zhou Y; Wang J; Yu J; Wu X; Lu Y; Mao L; Bosco MJ; Wang F; Sun Z
    Immunology; 2017 Jul; 151(3):280-290. PubMed ID: 28108989
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dual Roles for Regulatory T-cell Depletion and Costimulatory Signaling in Agonistic GITR Targeting for Tumor Immunotherapy.
    Mahne AE; Mauze S; Joyce-Shaikh B; Xia J; Bowman EP; Beebe AM; Cua DJ; Jain R
    Cancer Res; 2017 Mar; 77(5):1108-1118. PubMed ID: 28122327
    [TBL] [Abstract][Full Text] [Related]  

  • 55. TIGIT and CD155 as Immune-Modulator Receptor and Ligand on CD4
    Kamrani A; Soltani-Zangbar MS; Shiri S; Yousefzadeh Y; Pourakbari R; Aghebati-Maleki L; Mehdizadeh A; Danaii S; Jadidi-Niaragh F; Yousefi B; Kafil HS; Hojjat-Farsangi M; Motavalli R; Zolfaghari M; Haji-Fatahaliha M; Mahmoodpoor A; Ahmadian Heris J; Emdadi A; Yousefi M
    Immunol Invest; 2022 May; 51(4):1023-1038. PubMed ID: 33855917
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of T-cell immunoglobulin and immunoreceptor tyrosine-based inhibitory motif domain on CD4
    Kurita M; Yoshihara Y; Ishiuji Y; Chihara M; Ishiji T; Asahina A; Yanaba K
    J Dermatol; 2019 Jan; 46(1):37-42. PubMed ID: 30402886
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CD155/TIGIT signaling regulates the effector function of tumor-infiltrating CD8+ T cell by NF-κB pathway in colorectal cancer.
    Li S; Ding J; Wang Y; Wang X; Lv L
    J Gastroenterol Hepatol; 2022 Jan; 37(1):154-163. PubMed ID: 34734434
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Estrogen receptor β activation ameliorates DSS-induced chronic colitis by inhibiting inflammation and promoting Treg differentiation.
    Guo D; Liu X; Zeng C; Cheng L; Song G; Hou X; Zhu L; Zou K
    Int Immunopharmacol; 2019 Dec; 77():105971. PubMed ID: 31678865
    [TBL] [Abstract][Full Text] [Related]  

  • 59. TgMab-2: An Anti-human T Cell Immunoglobulin and Immunoreceptor Tyrosine-Based Inhibitory Motif Domain Monoclonal Antibody for Immunocytochemistry.
    Saito M; Suzuki H; Kaneko MK; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2022 Jun; 41(3):157-162. PubMed ID: 35736625
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Blockade of TIGIT/CD155 Signaling Reverses T-cell Exhaustion and Enhances Antitumor Capability in Head and Neck Squamous Cell Carcinoma.
    Wu L; Mao L; Liu JF; Chen L; Yu GT; Yang LL; Wu H; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
    Cancer Immunol Res; 2019 Oct; 7(10):1700-1713. PubMed ID: 31387897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.